PRESS RELEASE published on 05/04/2023 at 20:45, 3 years 2 months ago Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)
PRESS RELEASE published on 05/04/2023 at 10:30, 3 years 2 months ago Zur Rose Group has successfully completed the sale of its Swiss business to Migros
PRESS RELEASE published on 04/20/2023 at 07:00, 3 years 2 months ago Zur Rose Group: Revenue in the first quarter 2023 in line with plan
PRESS RELEASE published on 04/12/2023 at 07:00, 3 years 2 months ago Zur Rose Group AG publishes invitation to the Annual General Meeting on 4 May 2023
PRESS RELEASE published on 03/23/2023 at 07:00, 3 years 3 months ago Zur Rose Group: Revenue and earnings targets for 2022 achieved; significant step towards profitability
PRESS RELEASE published on 02/03/2023 at 07:00, 3 years 5 months ago Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany
PRESS RELEASE published on 01/19/2023 at 07:00, 3 years 5 months ago Zur Rose Group: Revenue target 2022 achieved, EBITDA better than expected
Published on 07/09/2026 at 13:35, 32 minutes ago Silver X Delivers Record Quarterly Production During the Second Quarter of 2026
Published on 07/09/2026 at 13:30, 37 minutes ago Stillwater Critical Minerals Expands 2026 Exploration Program and Provides Project Update
Published on 07/09/2026 at 13:00, 1 hour 7 minutes ago Evergold Mobilizes Drill to Golden Lion and Completes MobileMT Airborne Geophysical Survey, Toodoggone District, Northern BC
Published on 07/09/2026 at 13:00, 1 hour 7 minutes ago Jaguar Mining Reports Commencement of Directional Drilling Program at Pilar Gold Mine, Minas Gerais, Brazil
Published on 07/09/2026 at 12:35, 1 hour 32 minutes ago Cognizant to scale to 5,000 Frontier Certified Engineers and 10,000 Frontier Business Operators
Published on 07/09/2026 at 12:30, 1 hour 37 minutes ago Immunic to Participate in Investor Conferences in July
Published on 07/09/2026 at 12:16, 1 hour 51 minutes ago Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation
Published on 07/09/2026 at 13:56, 10 minutes ago Statement of transactions in own shares from July 6, 2026 to July 8, 2026
Published on 07/09/2026 at 13:56, 10 minutes ago Déclaration des transactions sur actions propres réalisées du 06/07/2026 au 08/07/2026
Published on 07/09/2026 at 07:30, 6 hours 37 minutes ago Half-year liquidity contract statement June 30, 2026
Published on 07/09/2026 at 07:30, 6 hours 37 minutes ago Half-year liquidity contract statement June 30, 2026
